Lloyd, F. MACKENZIE,Curtis HARWIG,David BOGUCKI,Jeffery, R. RAYMOND,Jeremy, D. PETTIGREW
申请号：
HK16106830.3
公开号：
HK1218747A
申请日:
2016.06.14
申请国别(地区):
HK
年份:
2017
代理人:
摘要：
Compounds of formula (I): where R1, R2, R3, R4a, R4b, R5, R6 and R7 are defined herein, or stereoisomers or pharmaceutically acceptable salts thereof, are described herein. Such compounds have activity as SHIP1 modulators, and thus may be used to treat any of a variety of diseases, disorders or conditions that would benefit from SHIP1 modulation. Compositions comprising a compound of formula (I) in combination with a pharmaceutically acceptable carrier or diluent are also disclosed, as are methods of SHIP1 modulation by administration of such compounds to an animal in need thereof.
